Haematology
The curricula for Advanced Training in Haematology has been redesigned. From 2026, first year trainees will be enrolled in the new curricula.
The Haematology curricula were redesigned through a 5-stage process. The new curricula have been widely consulted on and approved by the College Education Committee.
We're now working to carefully plan curriculum implementation from 2026. We'll let supervisors and trainees know by mid-2025 if there are any changes to the rollout timeline.
The new curricula are competency-based programs and include new learning goals, assessment tools, criteria for progression throughout the phases of training, and will be supported by a new technology platform, the Training Management Platform (TMP).
You can find the new curriculum support information and training resources at RACP Online Learning.
The new curricula
Adult Medicine
Paediatrics & Child Health
Subject matter experts
Specialist contractors
The specialist contractor developed an initial draft specialty curriculum in line with College-approved educational models and templates, quality standards, and project deadlines.
Associate Professor Tina Carter, MBBS, FRACP, PhD, FRCPA | Specialist contractor, Paediatrics & Child Health
Tina is the Head of the paediatric haematology service at Perth Children’s Hospital in WA. She's a clinical and laboratory haematologist and has been involved in clinical trials and translational research for over 25 years. Her clinical work in haematology includes the diagnosis of inherited bone marrow failure syndromes in children and their treatment. She has been a full member of the Children’s Oncology Group and Paediatric Bone Marrow Consortium since 2000. She is a FRACP and FRCPA supervisor and regularly contributes education sessions for medical students, registrars, nursing staff and haematology and oncology trainees in the QE2 laboratory and at PCH. She was also an executive member of the Australian Clinical Haemophilia Director’s organisation (6-year term finished last year). She has been the Standard 7 lead at PCH since 2017. She has been an editor for the Australian Journal of Paediatrics and Child Health since 2016. She regularly contributes and reviews articles in paediatric haematology.
Dr Jane Thompson, FRACP, FRCPA | Specialist contractor, Adult Internal Medicine
Jane is a clinical and laboratory haematologist and an NHMRC PhD fellow. She completed her undergraduate studies at The University of Adelaide and is a Fellow of both the Royal Australasian College of Physicians (FRACP) and the Royal College of Pathologists of Australasia (FRCPA). She underwent advanced training at The Royal Adelaide Hospital, Peter MacCallum Cancer Centre, and Royal Melbourne Hospital. She has research experience in iron deficiency and supplementation, as well as real-world costing of novel agents for the treatment of haematological malignancies. Currently, she's a PhD candidate at The South Australian Health and Medical Research Institute (SAHMRI), where she is exploring underlying genomics, novel fusions, rational treatment approaches, and drug resistance in Ph-like Acute Lymphoblastic Leukaemia. She is a haematologist & haematopathologist in private and holds a teaching role at The University of Adelaide Medical School.
Curriculum Review Group
The Curriculum Review Group reviewed and refined the draft curriculum in preparation for broad consultation.
See the Curriculum Review Group for Haematology Terms of Reference (PDF) for more information.
Members
Dr Phillip Choi, FRACP, FRCPA | Chair
Phil is a senior staff specialist in haematology at The Canberra Hospital, Clinical Director of the National Platelet Research and Referral Centre, Principal Editor of Platelets, honorary Senior Lecturer at the John Curtin School of Medical Research, Australian National University, and former co-chair of the Platelet Immunology Subcommittee of the ISTH. His research interests in classical haematology include improving the subclassification of ITP, management of HIT, and treatment of warm AIHA. His work is supported by an ACT Health Research and Innovation Fund grant. He is also current Treasurer of the Thrombosis and Haemostasis Society of Australia and New Zealand, advisory board member for ITP Australia and the National Blood Authority. He serves on advisory boards and speaker bureaus for industry including sobi, Novartis, and Johnson & Johnson Immunology.
Dr Rebecca Adams
Rebecca is a consultant haematologist at Sullivan Nicolaides Pathology, Brisbane where she reports across all areas of diagnostic haematology. She is the RCPA Chief Examiner in haematology, an associate fellow of the Royal Australasian College of Medical Administrators, a graduate member of the Australian Institute of Company Directors, and is also a director of the RCPA QAP. She has a strong interest in upholding the standards of haematology and ensuring the quality of training to ensure a strong and sustainable pathology workforce, and in her role as a pathology educator she was recognised with the Konrad Muller Outstanding Teaching Award by the RCPA in 2022.
Dr Pasquale Barbaro, FRACP, FRCPA
Pasquale is a joint RACP and RCPA trained paediatric haematologist currently working at the Queensland Children's Hospital. He has a particular interest in haemoglobinopathies and bone marrow failure syndromes. Additionally, he serves as the paediatric representative on the Committee for Joint College Training in Haematology.
Dr Caroline Bateman, FRACP
Associate Professor Andrea Henden, FRACP, FRCPA
Andrea is a clinical haematologist and bone marrow transplant physician at the Royal Brisbane and Women's Hospital in Brisbane, Australia, and holds a Metro North Clinician Research Fellowship. She has a clinical interest in transplantation and cellular therapies, and the infectious complications associated with these treatments. Andrea is also the research officer in the Translational Cancer Immunotherapy Laboratory at QIMR Berghofer Medical Research Institute. Her research focuses on transplant immunology, with current active projects including cellular therapies for COVID-19 and other infections, and the role of the microbiome on T cell function in the context of transplantation. She is the principal investigator on a number of investigator-initiated clinical trials bringing novel immunotherapies to the clinic, with a focus on treating complications of bone marrow transplantation.
Dr Stephanie Henderson, FRACP
Stephanie is a clinical and laboratory haematologist based in Melbourne. She is also the early career representative for the Haematology Society of Australia and New Zealand.
Dr Hannah Hsu, FRACP, FRCPA
Hannah is a consultant haematologist who specialises in managing patients with blood disorders, including lymphoma, myeloma, leukemia, myeloproliferative disorders, and myelodysplastic disorders. She is qualified as a consultant physician and specialist in clinical haematology, with additional qualifications as a haematopathologist. Hannah graduated from the Australian National University in 2013 and completed her specialist training at St George Hospital, St Vincent’s Hospital, Prince of Wales Hospital, and Wollongong Hospital in NSW. She attained Fellowship of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australia in 2022.
Hannah furthered her haematology training at University College Hospital in London during 2021 and 2022, gaining expertise in early phase clinical trials in haematology and specialised immunotherapy techniques such as CAR-T cell therapy and bi-specific antibodies.
Dr Alison Chandler
Alison is a fourth-year advanced trainee in the combined haematology training program.